Everest Group, Ltd. (EG) Stock Price & Analysis
Everest Group, Ltd. (EG) closed at USD 407.56 on Thursday, October 22, 2026, up 3.24% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 394.78; the Oct 22, 2026 session ranged USD 396.67–408.11 on volume of 355,406 shares. Market capitalization is $15.63B, with a 52-week range of USD 302.44–408.11 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:23 UTC.
Also available as compact Markdown for AI agents: nexqual.com/EG.md
Key facts (EG)
- Last four reported quarters (through Jun 30, 2026): revenue $16.8B, net income $1.91B (11.4% margin) (SEC filings).
- Valuation: P/E 8.2x (avg 8.7x at the last 3 fiscal year-ends).
- 4 of 80 tracked superinvestors hold EG (13F, Q2 2026): 0 new, 1 added, 3 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $273K; 1 not under a Rule 10b5-1 plan ($273K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.35 on a 1–5 scale) (17 analysts), mean target USD 409.81 (range 368–489).
- Total return with dividends: 1Y +18.8% vs S&P 500 +14.9%; 5Y +59.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 8.16, revenue estimate $3.03B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (EG)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $11.9B | $12.1B | $14.6B | $17.3B | $17.5B | $16.8B |
| Net income | $1.38B | $597M | $2.52B | $1.37B | $1.59B | $1.91B |
| EPS (diluted) | $34.62 | $15.19 | $60.19 | $31.78 | $37.80 | — |
| Net margin | 11.6% | 5.0% | 17.3% | 7.9% | 9.1% | 11.4% |
| Revenue growth | +23.6% | +1.6% | +21.0% | +18.5% | +1.2% | — |
| Cash + short-term investments | $375M | $283M | $308M | $331M | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (EG)
P/E 8.2x · P/S 0.9x · P/B 1.0x · Earnings yield 12.24% · Dividend yield (paid, TTM) 2.07% · Buyback yield (TTM) 7.18%
P/E at fiscal year-ends: Dec 2025 8.9x, Dec 2024 11.3x, Dec 2023 5.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (EG)
4 of 80 tracked investors hold EG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Vulcan Value Partners | 11.28% | $370M | Reduced -23.9% | |
| Sarah Ketterer | Causeway Capital Management | 0.98% | $90.3M | Added +1.1% |
| Christopher Davis | Davis Advisors | 0.19% | $45.2M | Reduced -10.3% |
| Van Den Berg Management I | 0.06% | $294K | Reduced -24.0% |
Insider sales (SEC Form 4, open-market, last ~7 months) (EG)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Keen Jason | EVP & CEO of GW & S Division | 775 | $273K | 8.7% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (EG)
Consensus Buy (mean 2.35 on a 1–5 scale), 17 analysts; mean target USD 409.81 (low 368, high 489).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Keefe, Bruyette & Woods | Target lowered | Outperform | $414 → $407 |
| 2026-10-07 | Mizuho | Target lowered | Neutral | $416 → $398 |
| 2026-09-22 | RBC Capital | Initiated | Outperform | $455 |
| 2026-08-19 | TD Cowen | Target raised | Hold | $365 → $385 |
| 2026-08-03 | UBS | Target raised | Neutral | $374 → $395 |
| 2026-07-31 | Citigroup | Target raised | Neutral | $395 → $415 |
| 2026-07-31 | Mizuho | Target lowered | Neutral | $418 → $416 |
| 2026-07-31 | Wells Fargo | Target raised | Equal-Weight | $373 → $396 |
| 2026-07-30 | Evercore ISI Group | Target raised | In-Line | $375 → $377 |
| 2026-07-30 | Barclays | Target raised | Overweight | $420 → $430 |
| 2026-07-10 | Evercore ISI Group | Target raised | In-Line | $365 → $375 |
| 2026-07-09 | Wells Fargo | Target raised | Equal-Weight | $356 → $373 |
Total return (dividends reinvested) (EG)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +18.8% | +59.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +18.8% | +9.8% |
| Volatility (annualized) | 24.3% | 24.4% |
| Max drawdown | -12.7% (Oct 2025→Oct 2025) | -22.6% (Sep 2024→Dec 2025) |
EG suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | AMERICAN INTERNATIONAL GROUP, INC. (AIG) | “On October 26, 2025, the Company entered into an agreement with American International Group, Inc. ("AIG") to sell the renewal rights for certain lines of commercial retail insurance business written by the Company in the U.S., U.K. and Asia Pacific, for an aggregate purchase price of $252 million.” |
Quoted from the company's 10-K filed Feb 26, 2026.
EG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $8.16 | $8.45 | -3.4% | $3.03B | 15 |
| Next quarter (ends Dec 2026) | $13.44 | $13.07 | +2.9% | $3.11B | 14 |
| Current fiscal year (ends Dec 2026) | $54.48 | $52.44 | +3.9% | $12.37B | 15 |
| Next fiscal year (ends Dec 2027) | $60.14 | $60.45 | -0.5% | $11.80B | 15 |
EG options: expected move
Options price a move of about ±6.8% (±$27.70) by Nov 20, 2026, which includes earnings on Oct 28, 2026. Over the last 8 reports the stock moved ±4% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 29.3% | ±6.8% |
| Dec 18, 2026 | 56 | 25.0% | ±7.9% |
| Jan 15, 2027 | 84 | 23.3% | ±9.0% |
| Apr 16, 2027 | 175 | 23.2% | ±12.8% |
| May 21, 2027 | 210 | 24.0% | ±14.6% |
30-day implied volatility 29% vs 18.6% realized over the last 30 trading days. Put/call ratio (volume) 0.15. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:23 UTC)
| Price | USD 407.56 |
|---|---|
| Change | ▲ 3.24% (up) |
| Previous Close | USD 394.78 |
| Open | USD 396.9 |
| Day Range | USD 396.67 – 408.11 |
| 52-Week Range | USD 302.44 – 408.11 |
| Volume | 355,406 shares |
| Market Cap | $15.63B |
| Exchange | NYQ |
Technical Analysis (EG)
Nexqual's technical model rates EG "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 75.82 (overbought) |
| vs SMA50 | Above (USD 374.83) |
| MACD | 6.52 (positive) |
Analyst Ratings (EG)
Wall Street analysts rate EG "Buy" based on 17 analysts, with a mean price target of USD 409.81 (range USD 368–489), per Nexqual as of October 23, 2026 at 09:23 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 409.81 |
| High Target | USD 489 |
| Low Target | USD 368 |
| Buy / Hold / Sell | 7 / 10 / 0 |
Earnings (EG)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 8.16 |
| Revenue Estimate | $3.03B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 14.85 vs est 14.53 ▲ beat |
| 2026-03-31 | USD 16.08 vs est 13.96 ▲ beat |
| 2025-12-31 | USD 13.26 vs est 13.83 ▼ miss |
| 2025-09-30 | USD 7.54 vs est 14.52 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financials & Fundamentals (EG)
| Total Revenue | $16.82B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -11.30% |
| Gross Margin | +15.28% |
| Operating Margin | +19.13% |
| Profit Margin | +11.38% |
| ROE | +12.57% |
| Debt / Equity | 0.23 |
| Current Ratio | 0.39 |
| Total Cash | $3.62B |
| Total Debt | $3.59B |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Financial Health Score (EG)
Nexqual rates Everest Group, Ltd.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:23 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 15% (last 12 months) |
| Balance Sheet | Solid — $3.62B cash vs $3.59B debt, net cash position |
| Cash Flow | Solid — Operating cash flow $3.07B (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 13%, ROA 2.5% |
Ownership (EG)
| Insider Ownership | +0.83% |
|---|---|
| Institutional Ownership | +105.54% |
| Shares Outstanding | 38.34M |
| Float | 35.71M |
| Short % of Float | +5.04% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
Leadership (EG)
Everest Group, Ltd. is led by James Allan Williamson, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:23 UTC.
| CEO, President & Director | James Allan Williamson |
|---|---|
| Group CFO & Executive VP | Elias Farid Habayeb |
| Executive Vice President of Group Operations & IT | Dean Brown |
Major Backers & Investors (EG)
Notable institutional backers of Everest Group, Ltd. include NORGES BANK, AQR Capital Management, LLC, Alliancebernstein L.P., according to Nexqual as of October 23, 2026 at 09:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| NORGES BANK | 5.03% |
| AQR Capital Management, LLC | 3.66% |
| Alliancebernstein L.P. | 2.72% |
| Vulcan Value Partners, LLC | 2.7% |
| Barrow, Hanley Mewhinney & Strauss, LLC | 2.56% |
| Invesco | 1.39% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.14% |
| BlackRock | 8.4% |
| State Street | 4.81% |
| Geode Capital | 3.01% |
Source: Nexqual, October 23, 2026 at 09:23 UTC.
From Everest Group, Ltd.'s Latest SEC 10-K Filing (filed 2026-02-26)
Partnerships
- On October 26, 2025, the Company entered into an agreement with American International Group, Inc. ("AIG") to sell the renewal rights for certain lines of commercial retail insurance business written by the Company in the U.S., U.K. and Asia Pacific, for an aggregate purchase price of $252 million.
- Management's best estimate is developed through collaboration with actuarial, underwriting, claims, legal and finance departments and culminates with the input of reserve committees.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be subject to legal, governmental or regulatory proceedings.
- The ownership of common shares of Group by Everest Re Advisors, Ltd., a direct subsidiary of Group, may have an impact on securing approval of shareholder proposals that Group's management supports.
- Group's bye-laws contain provisions that could delay or prevent a change of control that a shareholder might consider favorable.
- Group's bye-laws provide, as permitted by Bermuda law, that each director may appoint an alternate director, who shall have the power to attend and vote at any meeting of the Board or committee at which that director is not personally present and to sign written consents in place of that director.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RNR | RenaissanceRe Holdings Ltd. | USD 362.59 | ▲ 2.12% |
| RGA | Reinsurance Group of America, I | USD 272.05 | ▲ 1.07% |
| HG | Hamilton Insurance Group, Ltd. | USD 37.11 | ▲ 1.62% |
| SPNT | SiriusPoint Ltd. | USD 25.96 | ▲ 1.09% |
| GLRE | Greenlight Reinsurance, Ltd. | USD 15.3 | ▲ 2.41% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:23 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt